Molecular Diagnostics Market : Infectious Disease, Technology Trends and Applications

Research Report Insights Methodology and Scope Executive Summary Molecular Diagnostics Industry Insights Molecular Diagnostics Infectious Disease Insights Molecular Diagnostics Technology Insights Molecular Diagnostics Regional Insights Competitive Insights

Global Market Scenario of Molecular Diagnostics Molecular Diagnostics Market size, is poised to hit USD 10.03 billion by 2023; as per the latest research report by Global Market Insights, Inc. Strong and consistent regulatory support, encouraging R&D spending, and enhanced use of diagnostics in home healthcare is likely to drive the global molecular diagnostics market size. Sexually transmitted disease diagnostics will remain a major revenue puller, with revenue targeted to exceed USD 1.5 billion by 2023. HIV and STD illustrate maximum penetration due to increasing occurrence and ease of diagnosis. Revenue from Hepatitis C diagnostics was USD 529.5 million in 2015, with 8.8% CAGR growth anticipated for the next seven years. Chlamydia and Gonorrhea segments are forecast to see more than 9% CAGR gains.

Continue..... Growing demand for early disease detection, especially in case of cancer due to increase in awareness levels, and advanced technologies such as DNA sequencing and microarrays as well as use of healthcare IT to facilitate accurate diagnosis is anticipated to enhance molecular diagnostics market growth. The rising number of infectious diseases and hospital acquired infections (HAI) is slated to drive industry growth during the forecast timeframe. Moreover, growing incidence rates of target disorders such as cardiovascular, neurological and genetic disorders is also expected to boost demand. Dengue and tuberculosis, presently have moderate industry penetration, however they may expand in revenue share, if preventive care is not exercised in developing and under-developed nations.

Molecular diagnostics market size, by infectious diseases, 2014 - 2023 (USD Million)

360° Analysis Application Analysis:- In terms of technology, PCR is identified to be largest segment grabbing up to 46% molecular diagnostics market share in 2016. However, this share is expected to decline in the coming years due to the fact that other technologies such as in-situ hybridization and genetic sequencing are expected to experience an increase in demand over the forecast period. Regional Analysis:- North America, led by U.S. molecular diagnostics market size, is forecast to exceed USD 4.2 billion by 2023, remaining the largest regional industry. China and India molecular diagnostics market trend and outlook are significantly positive, with strong investment indicators for improving healthcare infrastructure along with implementation of policies promoting preventive healthcare treatments that facilitate higher diagnostic testing. Competitive Market Share:- Global molecular diagnostics market share was led by Roche Diagnostics, Abbott Laboratories, and Danaher Corporation, collectively grabbing a share of around 48% in 2015.products.

Latest Research Report On Aerial Imaging Market@ https://www.gminsights.com/industry-analysis/molecular-diagnostics-market Download Latest Report PDF @ https://www.gminsights.com/request-sample/detail/434

Stay In Touch You can visit us at: www.gminsights.com